PAR 2.38% 20.5¢ paradigm biopharmaceuticals limited..

The Humira comparative, and how about a bonus?, page-10

  1. 6,034 Posts.
    lightbulb Created with Sketch. 1162
    true, a quick google search has RA market at US$26.3BN in 2021 and has OA at US$11BN in 2025 (forecast)... of course a compelling drug could change that (well not by 2025)...
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.